Clinical Use Case Underscores Cagent Vascular’s Role in Critical Limb Ischemia Therapy

A LinkedIn post from Cagent Vascular Inc highlights a clinical case using the company’s Serration Remodeling Therapy (SRT) Serranator balloon in a critical limb ischemia patient with toe gangrene. The case description notes a stepwise endovascular approach, combining laser atherectomy with a 3.0 x 40 mm Serranator balloon to treat focal stenoses in the posterior tibial artery.

According to the post, final angiography in this case suggested no residual stenosis and strong luminal gain, supporting the device’s potential role in complex below‑the‑knee disease and limb salvage strategies. For investors, this type of case-based content may indicate ongoing clinical adoption efforts and could help build physician awareness, which, if scaled, may translate into greater procedure volume and revenue potential over time.

The focus on critical limb ischemia and peripheral arterial disease positions Cagent Vascular within a higher-acuity niche where payers and providers often prioritize limb-saving interventions. If similar outcomes are reproduced in broader clinical experience or formal studies, the company could strengthen its competitive stance in the endovascular market and enhance its prospects for partnerships, reimbursement support, or future exit opportunities.